3,4-tetrahydropyrimido[1,2-a]benzimidazole-4-carboxamides, were formed. Virtual screening and molecular docking of this class of compounds allowed us to consider them as potential CRF1 receptor antagonists.
研究了条件对
1,2-二氨基咪唑与N-芳基马来
酰亚胺反应过程的影响。结果表明,根据所用的反应条件,10-
氨基-N-芳基-2-氧代-2,3,4,10-四氢
嘧啶并[1,2- a ]
苯并咪唑-4-甲酰胺或其脱
氨基产物,形成N-芳基-2-氧代-1,2,3,4-四氢
嘧啶并[1,2- a ]
苯并咪唑-4-甲酰胺。此类化合物的虚拟筛选和分子对接使我们能够将它们视为潜在的 CRF1 受体拮抗剂。